Pastorino A, Sobrero A, Bruzzi P
BMJ Oncol. 2025; 2(1):e000179.
PMID: 39886497
PMC: 11234984.
DOI: 10.1136/bmjonc-2023-000179.
Thi Ha N, Youens D, Moorin R
Hypertens Res. 2025; .
PMID: 39837967
DOI: 10.1038/s41440-025-02116-z.
Xu T, Mostafavi A, Boot W, Czaja S, Kalantari S
Innov Aging. 2025; 9(1):igae099.
PMID: 39781245
PMC: 11705671.
DOI: 10.1093/geroni/igae099.
Mittal A, Kim M, Dunn S, Wright K, Gyawali B
EClinicalMedicine. 2025; 76():102824.
PMID: 39764569
PMC: 11701476.
DOI: 10.1016/j.eclinm.2024.102824.
Tregear M, Visco F
EClinicalMedicine. 2024; 76:102833.
PMID: 39309725
PMC: 11415949.
DOI: 10.1016/j.eclinm.2024.102833.
Rehabilitation outcomes of bird-building collision victims in the Northeastern United States.
Kornreich A, Partridge D, Youngblood M, Parkins K
PLoS One. 2024; 19(8):e0306362.
PMID: 39110767
PMC: 11305546.
DOI: 10.1371/journal.pone.0306362.
Clarifying Causal Effects of Interest and Underlying Assumptions in Randomized and Nonrandomized Clinical Trials in Oncology Using Directed Acyclic Graphs and Single-World Intervention Graphs.
Tanaka S, Muramatsu Y, Inoue K
JCO Clin Cancer Inform. 2024; 8:e2300262.
PMID: 38913964
PMC: 11371110.
DOI: 10.1200/CCI.23.00262.
Making evidence go further: Advancing synergy between agent-based modeling and randomized control trials.
Hammond R, Barkin S
Proc Natl Acad Sci U S A. 2024; 121(21):e2314993121.
PMID: 38748574
PMC: 11126991.
DOI: 10.1073/pnas.2314993121.
First-line oxaliplatin-based chemotherapy and nivolumab for metastatic microsatellite-stable colorectal cancer-the randomised METIMMOX trial.
Ree A, Saltyte Benth J, Hamre H, Kersten C, Hofsli E, Guren M
Br J Cancer. 2024; 130(12):1921-1928.
PMID: 38664577
PMC: 11183214.
DOI: 10.1038/s41416-024-02696-6.
Eliminating Bias in Survival Estimation: Statistical Bias Mitigation Is the First Step Forward.
Kohn R
Crit Care Med. 2024; 52(3):506-509.
PMID: 38381013
PMC: 10883595.
DOI: 10.1097/CCM.0000000000006110.
Comparative overall survival of CDK4/6 inhibitors in combination with endocrine therapy in advanced breast cancer.
Kappel C, Elliott M, Kumar V, Nadler M, Desnoyers A, Amir E
Sci Rep. 2024; 14(1):3129.
PMID: 38326452
PMC: 10850180.
DOI: 10.1038/s41598-024-53151-8.
Imputation of Missing Data for Time-to-Event Endpoints Using Retrieved Dropouts.
Wang S, Frederich R, Mancuso J
Ther Innov Regul Sci. 2023; 58(1):114-126.
PMID: 37805643
PMC: 10764582.
DOI: 10.1007/s43441-023-00575-5.
New OPTN/UNOS data demonstrates higher than previously reported waitlist mortality for lung transplant candidates supported with ECMO.
Lehr C, Schold J, Arrigain S, Valapour M
J Heart Lung Transplant. 2023; 42(10):1399-1407.
PMID: 37150472
PMC: 10524253.
DOI: 10.1016/j.healun.2023.04.017.
A review of 2022 Chinese clinical guidelines on the management of hepatocellular carcinoma: updates and insights.
Xie D, Zhu K, Ren Z, Zhou J, Fan J, Gao Q
Hepatobiliary Surg Nutr. 2023; 12(2):216-228.
PMID: 37124695
PMC: 10129899.
DOI: 10.21037/hbsn-22-469.
Estimating optimal individualized treatment rules with multistate processes.
Bakoyannis G
Biometrics. 2023; 79(4):2830-2842.
PMID: 37015010
PMC: 10553793.
DOI: 10.1111/biom.13864.
Informative Censoring-A Cause of Bias in Estimating COVID-19 Mortality Using Hospital Data.
Lin H, Liu S, Levin M, Williamson J, Bouvier N, Aberg J
Life (Basel). 2023; 13(1).
PMID: 36676159
PMC: 9865049.
DOI: 10.3390/life13010210.
Analysis of new treatments proposed for malignant pleural mesothelioma raises concerns about the conduction of clinical trials in oncology.
Meirson T, Nardone V, Pentimalli F, Markel G, Bomze D, dApolito M
J Transl Med. 2022; 20(1):593.
PMID: 36514092
PMC: 9749371.
DOI: 10.1186/s12967-022-03744-6.
The reliability and integrity of overall survival data based on follow-up records only and potential solutions to the challenges.
Huang H, Tang Y, Yu Y, Yu A, Wu D, Fang H
Lancet Reg Health West Pac. 2022; 31:100624.
PMID: 36426285
PMC: 9678947.
DOI: 10.1016/j.lanwpc.2022.100624.
Is treatment in certified cancer centers related to better survival in patients with pancreatic cancer? Evidence from a large German cohort study.
Roessler M, Schmitt J, Bobeth C, Gerken M, Tol K, Reissfelder C
BMC Cancer. 2022; 22(1):621.
PMID: 35672675
PMC: 9172168.
DOI: 10.1186/s12885-022-09731-w.
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update.
Reig M, Forner A, Rimola J, Ferrer-Fabrega J, Burrel M, Garcia-Criado A
J Hepatol. 2021; 76(3):681-693.
PMID: 34801630
PMC: 8866082.
DOI: 10.1016/j.jhep.2021.11.018.
